Here, we explored the connection between loss of IKZF1 function, AKT signaling and GC therapy resistance using an isogenic cell line model, normal B cells derived from Ikzf1+/- mice as well patient-derived ALL xenografts. Here, IKZF1 is linked to acute lymphoblastic leukemia.